Literature DB >> 17346894

Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.

P M B Cahusac1, H Wan.   

Abstract

Group II metabotropic (mGlu) receptors are known to play an important role in regulating the release of excitatory transmitter in a number of brain areas. Previous experiments demonstrated that (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) depressed excitatory transmission in the adult rat barrel cortex. Here we show, using in vivo extracellular single unit recordings and iontophoretic application of drugs, that selective activation of Group II mGlu receptors depresses excitatory but not inhibitory transmission. The selective Group II receptor agonist (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC) had similar depressant effects to 1S,3R-ACPD on tactile evoked responses of rapidly adapting neurons. The depressant effects were seen on shorter latency (<12 ms) responses, were most pronounced in layers 3-4 (and 5b for 2R,4R-APDC only), and were reversibly antagonized by the Group II receptor antagonist (2S)-alpha-ethylglutamic acid (EGLU) relative to depressions produced by iontophoretic GABA. Where 1S,3R-ACPD and 2R,4R-APDC depressed excitatory transmission, there was little or no effect on postsynaptic excitations produced by iontophoretic AMPA--a result that supports a presynaptic location of Group II receptors on excitatory terminals. To assess the possible involvement of Group II mGlu receptors in the modulation of inhibition, we studied the effect of iontophoretic 1S,3R-ACPD in a condition-test protocol. The results contrasted markedly from those previously observed using the Group III agonist L(+)-2-amino-4-phosphonobutyric acid in that activation of Group II receptors using 1S,3R-ACPD did not modulate inhibition. Therefore our results show that Group II mGlu receptors play an important role in modulating excitatory, but not inhibitory, transmission. We propose that the Group II mGlu receptors are located on excitatory terminals, and act as autoreceptors. Their role appears to be important in the early stages of cortical processing, by keeping excitatory inputs within specified physiological limits, and possibly by mediating depression evidenced during synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346894     DOI: 10.1016/j.neuroscience.2007.01.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Presynaptic inhibitory terminals are functionally abnormal in a rat model of posttraumatic epilepsy.

Authors:  Leonardo C Faria; David A Prince
Journal:  J Neurophysiol       Date:  2010-05-19       Impact factor: 2.714

2.  A modulatory effect of the feedback from higher visual areas to V1 in the mouse.

Authors:  Roberto De Pasquale; S Murray Sherman
Journal:  J Neurophysiol       Date:  2013-02-27       Impact factor: 2.714

3.  Modulatory effects of metabotropic glutamate receptors on local cortical circuits.

Authors:  Roberto De Pasquale; S Murray Sherman
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

4.  Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology.

Authors:  Jorge E Quintero; François Pomerleau; Peter Huettl; Kirk W Johnson; James Offord; Greg A Gerhardt
Journal:  Brain Res       Date:  2011-05-18       Impact factor: 3.252

5.  Developmental decline in modulation of glutamatergic synapses in layer IV of the barrel cortex by group II metabotropic glutamate receptors.

Authors:  Z Mateo; J T Porter
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

Review 6.  The Glutamatergic System in Primary Somatosensory Neurons and Its Involvement in Sensory Input-Dependent Plasticity.

Authors:  Julia Fernández-Montoya; Carlos Avendaño; Pilar Negredo
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.